Kerstin Becker

Kerpener Str. 62
Koeln, NW 50931, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

The Spirogyra pratensis genome illuminates the evolution of developmental programs and spiral chloroplast biology.

The Spirogyra pratensis genome illuminates the evolution of developmental programs and spiral chloroplast biology.

Journal: The Plant cell

Published: February 20, 2026

Frequent and clinically relevant germline DNA repair gene variants in young and familial myeloproliferative neoplasms.

Frequent and clinically relevant germline DNA repair gene variants in young and familial myeloproliferative neoplasms.

Journal: Blood cancer journal

Published: September 18, 2025

MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay.

MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay.

Journal: Blood

Published: September 15, 2025

MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay.

MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay.

Journal: Blood

Published: September 15, 2025

Reply to: Germline and Somatic BRCA1/2 Mutations in Breast Cancer Treatment Strategies.

Reply to: Germline and Somatic BRCA1/2 Mutations in Breast Cancer Treatment Strategies.

Journal: JCO precision oncology

Published: September 02, 2025

Reply to Lingyu Guo and Tian An's Letter to the Editor re: Mykyta Kachanov, Alexander E. Volk, Fabian Falkenbach, et al. Evaluation of Different National Comprehensive Cancer Network Clinical Practice Guidelines in Prostate Cancer for Germline Genetic Testing in Localized and Locally Recurrent Prostate Cancer. Eur Urol Focus. 2025;11:848-854.

Reply to Lingyu Guo and Tian An's Letter to the Editor re: Mykyta Kachanov, Alexander E. Volk, Fabian Falkenbach, et al. Evaluation of Different National Comprehensive Cancer Network Clinical Practice Guidelines in Prostate Cancer for Germline Genetic Testing in Localized and Locally Recurrent Prostate Cancer. Eur Urol Focus. 2025;11:848-854.

Journal: European urology focus

Published: July 18, 2025

Visual Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD).

Visual Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD).

Journal: Deutsches Arzteblatt international

Published: June 28, 2025

BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis.

BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis.

Journal: JCO precision oncology

Published: April 10, 2025

Evaluation of Different National Comprehensive Cancer Network Clinical Practice Guidelines in Prostate Cancer for Germline Genetic Testing in Localized and Locally Recurrent Prostate Cancer.

Evaluation of Different National Comprehensive Cancer Network Clinical Practice Guidelines in Prostate Cancer for Germline Genetic Testing in Localized and Locally Recurrent Prostate Cancer.

Journal: European urology focus

Published: February 19, 2025

Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia.

Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia.

Journal: Leukemia

Published: January 10, 2025

Joint analysis of germline genetic data from over 29,000 cases with suspected hereditary breast and ovarian cancer (HBOC) as part of the NASGE initiative.

Joint analysis of germline genetic data from over 29,000 cases with suspected hereditary breast and ovarian cancer (HBOC) as part of the NASGE initiative.

Journal: Breast (Edinburgh, Scotland)

Published: October 28, 2024

Lysine-11 ubiquitination drives type-I/III interferon induction by cGAS-STING and Toll-like receptors 3 and 4.

Lysine-11 ubiquitination drives type-I/III interferon induction by cGAS-STING and Toll-like receptors 3 and 4.

Journal: Nature cell biology

Published: October 21, 2024

Showing 1-12 of 57

Last Updated: 09/26/2026